Skip to content

Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function

TherapyGuide : Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01513538
Enrollment
700
Registered
2012-01-20
Start date
2011-05-31
Completion date
2013-10-31
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmia

Keywords

Pacemaker programming, Bradyarrhythmia

Brief summary

The technological progress allowed the development of more and more sophisticated pacemakers, widening the therapeutic indications but also meeting the physiological needs of the patient. This progress led to a more and more complex programming for the physicians. To help them set optimally the pacing parameters, physicians refer to the existing recommendations of learned societies as well as to his expertise. Manufacturers developed also algorithms integrated into pacemakers with the aim of assisting physicians in their programming. TherapyGuide is a function which proposes a programming adapted to the psychopathological state of the patient, with a justification based on experts' consensus, clinical studies as well as on published articles. Physicians have the choice to accept or reject the programming proposed by TherapyGuide. When rejected, there is no means to analyze the modifications brought to the proposed set of parameters. The nature, the frequency and the reasons of these modifications are not thus known. The purpose of this study is to assess the acceptance of the TherapyGuide proposals by physicians and to identify the most frequent type of programming changes they make and their rationale.

Interventions

DEVICETherapyGuide

Use of TherapyGuide function to help programming the device

Sponsors

Medtronic
CollaboratorINDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient implanted with a pacemaker featuring the TherapyGuide function * Patient more than 18 years of age. * Patient able to sign a data release authorization form

Exclusion criteria

\- Unwillingness or inability to provide written consent

Design outcomes

Primary

MeasureTime frameDescription
Acceptance of TherapyGuide Proposals and Typology of Programming Changes30 monthsThe primary objective is to assess the acceptance of the TherapyGuide proposals by the physicians. Acceptance will be assessed by measuring the proportion of cases where physicians programmed the set of parameters recommended by the TherapyGuide with no modifications.

Countries

France

Participant flow

Participants by arm

ArmCount
TherapyGuide
Patients implanted with a dual chamber pacemaker featuring the TherapyGuide function TherapyGuide: Use of TherapyGuide function to help programming the device
578
Total578

Baseline characteristics

CharacteristicTherapyGuide
Age, Customized
Men
77 years
Age, Customized
Women
79 years
Region of Enrollment
France
578 participants
Sex/Gender, Customized
Men
347 participants
Sex/Gender, Customized
Women
231 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Acceptance of TherapyGuide Proposals and Typology of Programming Changes

The primary objective is to assess the acceptance of the TherapyGuide proposals by the physicians. Acceptance will be assessed by measuring the proportion of cases where physicians programmed the set of parameters recommended by the TherapyGuide with no modifications.

Time frame: 30 months

ArmMeasureValue (NUMBER)
Patients Implanted With a Dual Chamber PacemakerAcceptance of TherapyGuide Proposals and Typology of Programming Changes46 percentage of patients

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026